tirzepatide shortage ending The end of a of popular weight-loss drugs may mean many people lose access to them FDA Resolves Tirzepatide Shortage: Impact

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study

Tirzepatide (Zepbound) is a drug that works in two ways

In parallel, a dietitian can help you set up simple, structured eating times, use easytotolerate foods (like smoothies, soups and soft proteins), and ensure you still meet minimum energy, protein and micronutrient needs despite low appetite.

Both require once-weekly injections

But beyond the question of Which works better? many people want to know: Which will I tolerate better? For some, side effects can be the deciding factor

They work in slightly different ways